These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 19629600)

  • 21. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
    Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.
    Yakabe T; Nakafusa Y; Sumi K; Miyoshi A; Kitajima Y; Sato S; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2010 Sep; 17(9):2349-56. PubMed ID: 20217258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
    Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
    Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F
    Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
    Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
    Forones NM; Tanaka M
    Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normalization of serum p53 antibody levels in patients after curative resection for colorectal cancer.
    Kawahara H; Watanabe K; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 May; 33(5):2221-5. PubMed ID: 23645779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.